HomeNewscoronavirusPharma wrap: WHO adds airborne transmission to modes of coronavirus spread; but is it coming too late?

Pharma wrap: WHO adds airborne transmission to modes of coronavirus spread; but is it coming too late?

Airborne transmission allows a virus to enter the upper and lower respiratory tracts.

July 11, 2020 / 20:13 IST
Story continues below Advertisement

This past week, the World Health Organization (WHO) has updated guidelines on modes of transmission of the virus causing COVID-19 by including the possibility in certain circumstances of airborne transmission. This means the coronavirus could be spread through tiny droplets called aerosols that linger in the air for long periods of time.

The update came on July 9, after an open letter signed by more than 200 scientists pressed the agency to acknowledge the potential role that aerosols play in airborne transmission among people in crowded, indoor settings for prolonged periods of time.

Story continues below Advertisement

The latest update is important because, after months of debate, the WHO has finally reconsidered its stance on airborne transmission. This will help countries frame appropriate infection control policies, as they try to ease lockdowns.

Airborne transmission allows a virus to enter the upper and lower respiratory tracts. Tuberculosis, chickenpox and measles are other diseases that are known to spread through airborne transmission.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show